Developing a scale to assess the psychosocial impact of comprehensive cancer genomic profiling testing

Observational study to develop a psychosocial impact assessment scale for patients undergoing comprehensive cancer genomic profiling testing - S-CAT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060507

Enrollment

150

Registered

2026-01-29

Start date

2026-01-29

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: *Patients receiving care at the National Cancer Center Hospital(Chuo Hospital and East Hospital), Tochigi Cancer Center, Juntendo University Hospital, Yokohama Municipal Citizen's Hospital, Toyama Prefectural Central Hospital, Nagoya City University Hospital, University Hospital,Kyoto Prefectural University of Medicine, Keio University Hospital, Tokyo Metropolitan Komagome Hospital, or Kanagawa Cancer Center *Patients who have been diagnosed with solid tumors and have received an explanation of their diagnosis from healthcare professionals, and for whom the attending physician judges that a basic understanding of the disease has been obtained *Patients who are able to read and understand Japanese study documents and questionnaires and complete them independently *Patients aged 18 years or older

Exclusion criteria

Exclusion criteria: *Individuals with difficulty reading or writing Japanese *Individuals deemed inappropriate for participation by the principal investigator

Design outcomes

Primary

Measure	Time frame
Multidimensional Impact of Cancer Risk Assessment for Comprehensive Genomic Profiling (MICRA-CGP)	—

Secondary

Measure	Time frame
Patient Health Questionnaire-9(PHQ-9) General Anxiety Disorder-7(GAD-7) Impact of Event Scale(IES) Patient Satisfaction Questionnaire(PSQ) Family APGAR Medical background: cancer type, disease stage(presence or absence of distant metastasis and recurrence), duration of clinical care Sociodemographic background: age, marital status, presence or absence of children, employment status, household income, and educational level	—

Measure

Time frame

Patient Health Questionnaire-9(PHQ-9) General Anxiety Disorder-7(GAD-7) *Impact of Event Scale(IES) *Patient Satisfaction *Questionnaire(PSQ) *Family APGAR *Medical background: cancer type, disease stage(presence or absence of distant metastasis and recurrence), duration of clinical care *Sociodemographic background: age, marital status, presence or absence of children, employment status, household income, and educational level

—

Countries

Japan

Contacts

Public ContactMaiko Fujimori

National Cancer Center Institute for Cancer Control Division of Supportive Care, Survivorship and Translational Research

mfujimor@ncc.go.jp03-3547-5201(3328)

Outcome results